|
Immediate changes in fluid volume and blood chemistry following overnight automated peritoneal dialysis
Dr Neil C Boudville, University of Western Australia, Australia
|
|
Balance vs Conventional Peritoneal Dialysis Fluid: Are there measurable benefits?
Dr Melinda M Tee, Monash Medical Centre and Monash University, Australia
|
|
Maintaining nutrition, dialysis adequacy and membrane function over time using APD with day time dry period
Dr Stephen J May, TBH, Australia
|
|
Medicated honey to treat difficult exit infections
Dr Stephen J May, Tamworth Base Hospital NSW, Australia
|
|
Unusual complications of Peritoneal Dialysis
Dr Valli Manickam, Royal Brisbane and Women's Hospital, Australia
|
|
Predictors of recovery of dialysis-independent renal function in Australian and New Zealand patients treated with peritoneal dialysis
Dr Ann-Maree S Craven, ANZDATA Registry, Adelaide; Dept of Renal Medicine, Princess Alexandra Hospital, Brisbane, Australia
|
|
A Randomized, Controlled Trial of Coiled Versus Straight Swan Neck Tenckhoff Catheters in Peritoneal Dialysis Patients
Jennifer S Wong, Princess Alexandra Hospital, Australia
|
|
Introduction of a Physician Managed Percutaneously Inserted Cuffed Tunnelled Haemodialysis Catheter Program Reduces Burden on Surgical Dialysis Access Theatre Lists - A Single Centre Experience
Ananthakrishnapuram Aravindan, Liverpool Hospital, Australia
|
|
Dialysis access insufficiency: How big a problem is it?
Dr Naresh Chetana, Statewide Renal Services, Australia
|
|
Palliative Care: Quality of life, not end of life. A study in symptom management for patients on hospital haemodialysis
Elizabeth A Keen, St George Hospital, Australia
|
|
Blood Pressure and Weight Trends over the First 12 Weeks of Haemodialysis: A Retrospective Incident Cohort Study
Suetonia Palmer, Christchurch Hospital, New Zealand
|
|
The dose equivalent ratio for intravenous epoetin alfa and intravenous darbepoetin alfa used in Australian haemodialysis patients
Prof Rowan Walker, Royal Melbourne Hospital, Australia
|
|
Iron replacement in inflammation: is supplemental iron of benefit?
Gavin Dreyer, Department of Nephrology, Royal Darwin Hospital, Australia
|
|
Protocolised Management of Anaemia in Haemodialysis Patients
Dr Krishan K Madhan, Taranaki Base Hospital, New Plymouth, New Zealand
|
|
Quality of Anaemia Management in Haemodialysis Patients by Nurse Practitioners and Anaemia Co-ordinator
Dr Michael J Desmond, Department of Nephrology, St Vincent's Hospital Melbourne, Australia
|
|
Treatment of renal anaemia and guideline adherence: a pan-European survey experience
Prof Francesco Locatelli, A. Manzoni Hospital, Lecco, Italy
|
|
Intravenous N-Acetylcysteine during Haemodialysis Reduces the Plasma Concentration of Homocysteine in Patients with End-Stage Renal Disease
Mochammad Thaha, Department of Internal Medicine, Airlangga School of Medicine, Dr Soetomo Teaching Hospital, Surabaya, Indonesia
|
|
Initial Patient Experience with Cinacalcet in dialysis patients with severe Secondary Hyperparathyroid Disease (SHPT)
Dr Kumar Mahadevan, The Queen Elizabeth Hospital & Health Service, Australia
|
|
Serum phosphate is an important determinant of corrected serum calcium in end-stage renal disease
Richard Singer, Fremantle Hospital, University of Western Australia, Australia
|
|
Controlled Blood volume monitoring does not promote treatment tolerance in hypotension-prone patients
Natasha M Rogers, The Queen Elizabeth Hospital, Australia
|
|
Development of polycythaemia in a previously erythropoietin dependant haemodialysis patient after the onset of severe idiopathic pulmonary hypertension
Dr Duncan R Cooke, Launceston General Hospital, Australia
|
|
Markedly elevated BNP levels detect left ventricular systolic dysfunction in asymptomatic dialysis patients
Matthew A Roberts, Austin Health, Australia
|
|
25-Hydroxyvitamin D Deficiency Is Common in a Prevalent Australian Haemodialysis Population
Dr Michael J Desmond, Department of Nephrology, St Vincent’s Hospital, Melbourne, Australia
|
|
CRP in Nocturnal Haemodialysis Patients
Carolyn J Clark, Barwon Health, Australia
|
|
Combination biomarker screening strongly predicts mortality in asymptomatic patients receiving dialysis
Matthew A Roberts, Austin Health, Australia
|